Published in Gene Therapy Weekly, July 8th, 2004
"Estrogen receptor (ER)-negative breast carcinomas are often difficult to treat with antiestrogens. This work was performed to determine if the re-expression of the human ERalpha could restore the hormone response of these cells. We have transfected the human wild-type ERalpha to an ER-negative breast cancer cell line (MDA-MB-231) using a tetracycline-regulated gene expression system," investigators in Mexico reported.
"We obtained a new cell line, MDA-A4-5/2. Cell count and flow cytometry ''S'' phase cell fraction showed that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.